SCHEMBL6818663

SCHEMBL6818663

Cc1nc(=O)c2ccccc2[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.52
KDM4E B2RXH2 5/20 0.52
CYP1A2 P05177 4/20 0.52
ALDH1A1 P00352 4/20 0.52
TNKS2 Q9H2K2 3/20 0.52
LMNA P02545 2/20 0.52
HSD17B10 Q99714 2/20 0.52
MEN1 O00255 1/20 0.52
TNKS O95271 1/20 0.52
GPR3 P46089 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
KMT2A Q03164 1/20 0.52
PARP15 Q460N3 1/20 0.52
DAO P14920 1/20 0.51
DDO Q99489 1/20 0.51
CHEK1 O14757 1/20 0.49
CYP2C19 P33261 1/20 0.47
MAPT P10636 1/20 0.47
IDE P14735 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590490 0.81 ALDH1A1 (0.61) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL30293081 0.77 ALDH1A1 (0.58) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL530191 0.77 ALDH1A1 (0.58) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL1589916 0.77 PLAUR (0.61) KDM4EALDH1A1LMNAHSD17B10MEN1
SCHEMBL30617972 0.77 PLAUR (0.61) KDM4EALDH1A1LMNAHSD17B10MEN1
SCHEMBL16540988 0.76 CHEK1 (0.55) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL6887071 0.76 ALDH1A1 (0.52) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL30014118 0.75 NPC1 (0.52) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL577953 0.75 NPC1 (0.52) PARP1KDM4ECYP1A2ALDH1A1TNKS2
SCHEMBL2961350 0.74 KDM4E (0.47) PARP1KDM4ECYP1A2ALDH1A1TNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1093372-A4 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS ELAN PHARM INC (US) 2004-09-29 EP disclosed
EP-1093372-A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS Elan Pharmaceuticals, Inc. (US) 2001-04-25 EP disclosed
WO-1999066934-A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 1999-12-29 WO disclosed
EP-0730453-A4 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO INC (US) 1998-03-04 EP disclosed
EP-0730453-A1 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO. INC. (US) 1996-09-11 EP disclosed
WO-1995014470-A1 METHODS OF TREATING CARDIAC ARRHYTHMIA MERCK & CO., INC. (US) 1995-06-01 WO disclosed